A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).

Clinical trial NCT01451541 · COMPLETED

Trial details

NCT number: NCT01451541
Sponsor: Sumitomo Pharma America, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Perennial Allergic Rhinitis PAR

Start date: 2011-10-01
Primary completion: 2012-12-01
Enrollment: 848

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.